Biomendi S.A.U. Report issue

For profit Phase 3
Founded: Bernedo Spain (1992)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2012
NCT02254525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

ibuprofen (motrin) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2